4/A//SEC Filing
NAGASAKI YASUSHI 4/A
Accession 0001140361-11-048967
CIK 0001420031other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 9:17 AM ET
Size
6.1 KB
Accession
0001140361-11-048967
Insider Transaction Report
Form 4/AAmended
NAGASAKI YASUSHI
Chief Financial Officer
Transactions
- Other
Convertible Promissory Note
2011-06-29$360000.00/sh→ 100,000 totalExercise: $3.60From: 2011-06-29Exp: 2012-06-29→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the number of Convertible Shares previously reported and to include the interest rate on the Convertible Promissory Note.
- [F2]The principal amount of the Convertible Promissory Note plus unpaid accrued interest (8% per annum) is convertible into shares of the Issuer's common stock. The 100,000 shares represents the number of shares into which the principal amount of the Convertible Promissory Note may be converted (the "Convertible Shares').
Documents
Issuer
EMMAUS LIFE SCIENCES, INC.
CIK 0001420031
Entity typeother
Related Parties
1- filerCIK 0001517916
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 9:17 AM ET
- Size
- 6.1 KB